Trinity Biotech Stock News

Conference Call Scheduled for June 30, 2022 at 11:00 am EASTERN Conference Call Scheduled for June 30, 2022 at 11:00 am EASTERN

Conference Call Scheduled for June 30, 2022 at 11:00 am EASTERN Conference Call Scheduled for June 30, 2022 at 11:00 am EASTERN

DUBLIN, Ireland, May 20, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) has achieved a CE Mark for its 10-minute Covid-19 antigen test. This CE mark allows for use by healthcare profess

DUBLIN, Ireland, May 03, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory market

DUBLIN, Ireland, April 11, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading global diagnostic company (“Trinity Biotech” or the “Company”), today announced a $45 millio

Trinity Biotech plc (NASDAQ: TRIB) announced a $45 million investment and partnership with MiCo Ltd, a KOSDAQ-listed and Korea-based company. MiCo is engaged in the biomedical business through its

In today’s recent session, 1.08 million shares of the Trinity Biotech plc (NASDAQ:TRIB) have been traded, and its beta is 1.52. Most recently the company’s share price was $1.11, and it changed around -$0.02 or -1.78% from the last close, which brings the market valuation of the company to $24.70M. TRIB at last check was … Trinity Biotech plc (NASDAQ: TRIB) Share Price Might Move Down By -82.06% Read More »

Trinity Biotech (TRIB) announced on Monday that the World Health Organisation ((WHO)) approved its new HIV screening product, TrinScreen HIV.In Africa, Trinity Biotech (TRIB) has led…

Dublin-based Trinity Biotech Plc shares jumped 6% premarket Monday, after the company said it has received approval from the World Health Organization for its HIV screening product, TrinScreen. The company''s Uni-Gold HIV product has served as the main confirmatory test for the detection of HIV in Africa for many years. The new product is expected to have an estimated market size of more than $150 million. "TrinScreen(TM) HIV is a rapid test providing results in less than 12 minutes from a finger stick drop of blood and the test has demonstrated excellent performance in both an independent evaluation sponsored by the WHO and in a multi-centre clinical evaluation conducted in Africa in 2020 by the Company," Trinity said in a statement. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

DUBLIN, Ireland, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) has received approval for its new HIV screening product, TrinScreen™ HIV, from the World Health Organisation (

Dublin-based Trinity Biotech Plc shares TRIB, -4.24% jumped 6% premarket Monday, after the company said it has received approval from the World Health Organization for its HIV screening product, TrinS

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Biogen To Sell Stake In Biosimilar JV With Samsung Bioepis For Up to $2.3B Biogen, Inc. (NASDAQ: BIIB)

DUBLIN, Ireland, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory marke

DUBLIN, Ireland, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory marke

Trinity Biotech Plc - ADR (TRIB) shares closed today at 0.8% above its 52 week low of $1.30, giving the company a market cap of $27M. The stock is currently down 8.4% year-to-date, down 67.2% over the past 12 months, and down 80.9% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 73.8% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 3.0% The company's stock price performance over the past 12 months lags the peer average by 511.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.